Confined migration promotes cancer metastasis through resistance to anoikis and increased invasiveness
Deborah Fanfone,
Zhichong Wu,
Jade Mammi,
Kevin Berthenet,
David Neves,
Kathrin Weber,
Andrea Halaburkova,
François Virard,
Félix Bunel,
Catherine Jamard,
Hector Hernandez-Vargas,
Stephen WG Tait,
Ana Hennino,
Gabriel Ichim
Affiliations
Deborah Fanfone
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université de Lyon, Lyon, France
Zhichong Wu
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Université Lyon 1, Villeurbanne, Villeurbanne, France; Centre Léon Bérard, Lyon, France; Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Jade Mammi
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université de Lyon, Lyon, France
Kevin Berthenet
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université de Lyon, Lyon, France; Centre Léon Bérard, Lyon, France
David Neves
Netris Pharma, Lyon, France
Kathrin Weber
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université de Lyon, Lyon, France
Andrea Halaburkova
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université de Lyon, Lyon, France
François Virard
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Université Claude Bernard Lyon 1, Faculté d’Odontologie, Hospices Civils de Lyon, Lyon, France
Félix Bunel
ENS de Lyon, Université Claude Bernard Lyon 1, CNRS, Laboratoire de Physique, Lyon, France
Catherine Jamard
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université de Lyon, Lyon, France
Hector Hernandez-Vargas
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon 1, Lyon, France
Stephen WG Tait
Cancer Research UK Beatson Institute, Glasgow, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom
Ana Hennino
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Université Lyon 1, Villeurbanne, Villeurbanne, France; Centre Léon Bérard, Lyon, France
Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France; Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université de Lyon, Lyon, France
Mechanical stress is known to fuel several hallmarks of cancer, ranging from genome instability to uncontrolled proliferation or invasion. Cancer cells are constantly challenged by mechanical stresses not only in the primary tumour but also during metastasis. However, this latter has seldom been studied with regards to mechanobiology, in particular resistance to anoikis, a cell death programme triggered by loss of cell adhesion. Here, we show in vitro that migrating breast cancer cells develop resistance to anoikis following their passage through microporous membranes mimicking confined migration (CM), a mechanical constriction that cancer cells encounter during metastasis. This CM-induced resistance was mediated by Inhibitory of Apoptosis Proteins, and sensitivity to anoikis could be restored after their inhibition using second mitochondria-derived activator of caspase (SMAC) mimetics. Anoikis-resistant mechanically stressed cancer cells displayed enhanced cell motility and evasion from natural killer cell-mediated immune surveillance, as well as a marked advantage to form lung metastatic lesions in mice. Our findings reveal that CM increases the metastatic potential of breast cancer cells.